WFA of San Diego’s Ionis Pharmaceuticals IONS Stock Holding History

WFA of San Diego’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200	Closed	-$7K	–	224
2022 Q2	$7K	Buy	+200	New	+$7.54K	0.01%	300

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

WFA of San Diego's IONS Position: Q3 2022 in Review

WFA of San Diego sold out of Ionis Pharmaceuticals (IONS) in Q3 2022, closing a stake of 200 shares — an estimated $7K sold.

WFA of San Diego first reported a position in IONS in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

WFA of San Diego reported no remaining Ionis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
WFA of San Diego sold 200 Ionis Pharmaceuticals shares in Q3 2022, an estimated $7K.
WFA of San Diego first reported a position in Ionis Pharmaceuticals in Q2 2022 and held it in 1 quarter.
WFA of San Diego's Ionis Pharmaceuticals position peaked at $7K in Q2 2022.
349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on WFA of San Diego's 13F filing for Q3 2022, filed 18 Oct 2022.